跳至主要内容
临床试验/NCT03074812
NCT03074812
暂停
不适用

Exploring Mechanisms for Neuropsychiatric Symptoms of Parkinson Disease Using Transcranial Direct Current Stimulation

Johns Hopkins University1 个研究点 分布在 1 个国家目标入组 80 人2016年2月1日

概览

阶段
不适用
干预措施
Transcranial Direct Current Stimulation
疾病 / 适应症
Idiopathic Parkinson's Disease
发起方
Johns Hopkins University
入组人数
80
试验地点
1
主要终点
Number of Participants Demonstrating improvements on Objective Rating Scales of Depression via structured interview
状态
暂停
最后更新
2个月前

概览

简要总结

This study evaluates the effect of transcranial direct current stimulation (tDCS) on non-motor symptoms of Parkinson's disease, including depression and cognitive symptoms. Participants are randomized to receive active or sham tDCS for 30 minutes over 10 treatment sessions.

注册库
clinicaltrials.gov
开始日期
2016年2月1日
结束日期
2028年10月1日
最后更新
2个月前
研究类型
Interventional
研究设计
Parallel
性别
All

研究者

责任方
Sponsor

入排标准

入选标准

  • Abel to provide written informed consent is obtained in the English language
  • Age 18 to 95 years old
  • Movement Disorder Society Clinical Diagnostic Criteria for probable idiopathic Parkinson disease
  • Report disabling depressive or neuropsychiatric symptoms prior to study entry
  • Capacity to understand the nature of the study;

排除标准

  • Known structural brain disease such as a neoplasm, abscess etc.
  • Pre-existing skull / scalp defects that would impede standardized electrode placement
  • Current electronic or metal implants
  • Diagnosis of Bipolar Disorder, Post-Traumatic Stress Disorder, a Psychotic Disorder or any other non-unipolar depressive disorder as a principal diagnosis in the 6 months prior to screening;
  • Concurrent treatment with medication which may affect tDCS (benzodiazepines, anticonvulsants, dextromethorphan and pseudoephedrine)
  • Endorse active suicidal ideation at enrollment or during any study visit, or have attempted suicide in the six months prior to screening;
  • History of substance abuse or dependence in the 2 months prior to screening;
  • Considered to be at significant risk of committing homicide;
  • Unstable medical condition;
  • Score less than 22 on the Montreal Cognitive Assessment (MoCA)

研究组 & 干预措施

Sham tDCS

Sham transcranial direct current stimulation where current will be reduced to zero after standardized ramp up to 2 mA

干预措施: Transcranial Direct Current Stimulation

Active tDCS

Transcranial direct current stimulation according to protocol maintained for 30 minutes after ramping up to 2 mA

干预措施: Transcranial Direct Current Stimulation

结局指标

主要结局

Number of Participants Demonstrating improvements on Objective Rating Scales of Depression via structured interview

时间窗: 1 months

Primary outcome measure will be the number of participants who demonstrate remission of depressive symptoms OR improvement of 50% (i.e. response) on the Montgomery-Asberg Scale of Depression (MADRS)

次要结局

  • Subjective improvement of Anxiety Symptoms via Rating Scale(1 month)
  • Performance on abbreviated cognitive battery(1 month)
  • Subjective Depression Severity rated via self-report on depression inventory(1 months)
  • Apathy Scores as measure by a self-report scale (the Apathy Scale)(1 months)
  • Subjective reactive to pleasure (i.e. improvement of anhedonia) as rated via self-report(1 month)
  • Improvement of Parkinsonian Motor Symptoms(1 month)

研究点 (1)

Loading locations...

相似试验